PROTEOSYS AG

Organization

Mainz, DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Muscarinic antagonists with parp and sir modulating activity as cyt...
- Patent number 8,466,144
- Issue date Jun 18, 2013
- Proteosys AG
- André Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Annexin A3 for cancer diagnosis
- Patent number 8,409,812
- Issue date Apr 2, 2013
- ProteoSys AG
- Michael Cahill
- G01 - MEASURING TESTING
Information Patent Grant
Autoimmune regulation of prostate cancer by annexin A3
- Patent number 8,377,648
- Issue date Feb 19, 2013
- Proteosys AG
- Andre Schrattenholz
- G01 - MEASURING TESTING
Information Patent Grant
Muscarinic antagonists with PARP and SIR modulating activity as age...
- Patent number 8,039,464
- Issue date Oct 18, 2011
- Proteosys AG
- André Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal anti-annexin A3 antibodies for the detection of prostate...
- Patent number 8,012,697
- Issue date Sep 6, 2011
- Proteosys AG
- Andre Schrattenholz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of finasteride, dutasteride and related compounds for the preve...
- Patent number 7,998,970
- Issue date Aug 16, 2011
- Proteosys AG
- Vukic Soskic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neuregulin-β isoforms associated with neuronal processes
- Patent number 7,824,923
- Issue date Nov 2, 2010
- Proteosys AG
- André Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of substances for treating tumors
- Patent number 7,759,068
- Issue date Jul 20, 2010
- Proteosys AG
- Michael Cahill
- G01 - MEASURING TESTING
Information Patent Grant
Annexin A3 for prostate cancer diagnosis
- Patent number 7,732,148
- Issue date Jun 8, 2010
- ProteoSys AG
- Michael Cahill
- G01 - MEASURING TESTING
Information Patent Grant
Use of neuregulin-β as an indicator and/or target
- Patent number 7,538,197
- Issue date May 26, 2009
- Proteosys AG
- André Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF INHIBITING DOPAMINERGIC CELL DEATH
- Publication number 20140323408
- Publication date Oct 30, 2014
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIRENZEPINE AS AN AGENT IN CANCER TREATMENT
- Publication number 20140271922
- Publication date Sep 18, 2014
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS
- Publication number 20140243269
- Publication date Aug 28, 2014
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION CONTAINING NEUREGULIN ISOFORMS
- Publication number 20140243270
- Publication date Aug 28, 2014
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIRENZEPINE AS AN AGENT IN CANCER TREATMENT
- Publication number 20110294791
- Publication date Dec 1, 2011
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIRENZEPINE AS OTOPROTECTIVE AGENT
- Publication number 20110263574
- Publication date Oct 27, 2011
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIBODIES RECOGNIZING NATIVE ANNEXIN A3
- Publication number 20110177536
- Publication date Jul 21, 2011
- PROTEOSYS AG
- Slobodan Poznanovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN BIOMARKERS FOR IN VITRO TESTING OF DEVELOPMENTAL TOXICITY A...
- Publication number 20110143366
- Publication date Jun 16, 2011
- PROTEOSYS AG
- Andre Schrattenholz
- G01 - MEASURING TESTING
Information Patent Application
ANNEXIN FOR CANCER RISK ASSESSMENT
- Publication number 20100267051
- Publication date Oct 21, 2010
- ProteoSys AG, a corporation of Germany
- Michael Cahill
- G01 - MEASURING TESTING
Information Patent Application
ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
- Publication number 20100256066
- Publication date Oct 7, 2010
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate...
- Publication number 20100233160
- Publication date Sep 16, 2010
- PROTEOSYS AG
- Andre Schrattenholz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AUTOIMMUNE REGULATION OF PROSTATE CANCER BY ANNEXIN A3
- Publication number 20100129834
- Publication date May 27, 2010
- PROTEOSYS AG
- Andre Schrattenholz
- G01 - MEASURING TESTING
Information Patent Application
Use of at least one isoform of progesterone receptor membrane compo...
- Publication number 20090318354
- Publication date Dec 24, 2009
- PROTEOSYS AG
- Michael Cahill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF NEUREGULIN-BETA AS AN INDICATOR AND/OR TARGET
- Publication number 20090286273
- Publication date Nov 19, 2009
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF FINASTERIDE, DUTASTERIDE AND RELATED COMPOUNDS FOR THE PREVE...
- Publication number 20090170889
- Publication date Jul 2, 2009
- PROTEOSYS AG
- Vukic Soskic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Annexin for Cancer Risk Assessment
- Publication number 20080200385
- Publication date Aug 21, 2008
- ProteoSys AG, a corporation of Germany,
- Michael Cahill
- G01 - MEASURING TESTING
Information Patent Application
Enrichment of Enzymatic Cleavage Products
- Publication number 20070298448
- Publication date Dec 27, 2007
- PROTEOSYS AG
- Vukic Soskic
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
Muscarinic Antagonists With Parp and Sir Modulating Activity as Cyt...
- Publication number 20070265251
- Publication date Nov 15, 2007
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Muscarinic Antagonists With Parp and Sir Modulating Activity as Age...
- Publication number 20070207998
- Publication date Sep 6, 2007
- PROTEOSYS AG
- Andre Schrattenholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diagnostic marker for cancer
- Publication number 20070172900
- Publication date Jul 26, 2007
- PROTEOSYS AG
- Michael Cahill
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks

Information Trademark
78071352 - PROTEODYN
- Serial number 78071352
- Registration number 2635372
- Filing date Jun 27, 2001
- ProteoSys AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
78068479 - PROTEOSYS
- Serial number 78068479
- Registration number 2786215
- Filing date Jun 11, 2001
- ProteoSys AG
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
78065800 - PROTEOSYS
- Serial number 78065800
- Registration number 2709369
- Filing date May 25, 2001
- ProteoSys AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments

PROTEOSYS AG

Organization

Patents Grantslast 30 patents

Muscarinic antagonists with parp and sir modulating activity as cyt...

Annexin A3 for cancer diagnosis

Autoimmune regulation of prostate cancer by annexin A3

Muscarinic antagonists with PARP and SIR modulating activity as age...

Monoclonal anti-annexin A3 antibodies for the detection of prostate...

Use of finasteride, dutasteride and related compounds for the preve...

Neuregulin-β isoforms associated with neuronal processes

Use of substances for treating tumors

Annexin A3 for prostate cancer diagnosis

Use of neuregulin-β as an indicator and/or target

Patents Applicationslast 30 patents

METHOD OF INHIBITING DOPAMINERGIC CELL DEATH

PIRENZEPINE AS AN AGENT IN CANCER TREATMENT

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

PHARMACEUTICAL COMPOSITION CONTAINING NEUREGULIN ISOFORMS

PIRENZEPINE AS AN AGENT IN CANCER TREATMENT

PIRENZEPINE AS OTOPROTECTIVE AGENT

NOVEL ANTIBODIES RECOGNIZING NATIVE ANNEXIN A3

PROTEIN BIOMARKERS FOR IN VITRO TESTING OF DEVELOPMENTAL TOXICITY A...

ANNEXIN FOR CANCER RISK ASSESSMENT

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate...

AUTOIMMUNE REGULATION OF PROSTATE CANCER BY ANNEXIN A3

Use of at least one isoform of progesterone receptor membrane compo...

USE OF NEUREGULIN-BETA AS AN INDICATOR AND/OR TARGET

USE OF FINASTERIDE, DUTASTERIDE AND RELATED COMPOUNDS FOR THE PREVE...

Annexin for Cancer Risk Assessment

Enrichment of Enzymatic Cleavage Products

Muscarinic Antagonists With Parp and Sir Modulating Activity as Cyt...

Muscarinic Antagonists With Parp and Sir Modulating Activity as Age...

Diagnostic marker for cancer

Trademarklast 30 trademarks

78071352 - PROTEODYN

78068479 - PROTEOSYS

78065800 - PROTEOSYS